id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2022-D-2899-0005,FDA,FDA-2022-D-2899,"Effectiveness of Anthelmintics: Specific Recommendations for Products Proposed for the Prevention of Heartworm Disease in Dogs; Draft Guidance for Industry; Availability;
 Extension of Comment Period",Notice,Extension of Comment Period,2023-01-20T05:00:00Z,2023,1,2023-01-20T05:00:00Z,,2023-01-20T15:34:36Z,2023-01031,0,0,09000064855fbdfb